Pulmonary Embolism Recruiting Phase 4 Trials for Dabigatran (DB14726)

Also known as: Pulmonary Embolus / Pulmonary emboli / Embolism, Pulmonary / Pulmonary Embolus/Emboli / PE - Pulmonary Embolism / Pulmonary Embolism (PE) / PE / Embolus pulmonary / Embolism lung / Acute pulmonary embolism NOS / Embolism pulmonary

IndicationStatusPhase
DBCOND0027915 (Pulmonary Embolism)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02596555Low Molecular Weight Heparin for 72 Hours Followed by Dabigatran for Acute Intermediate-Risk Pulmonary Embolism.Treatment
NCT02979561Pradaxa or Warfarin for Prevention of Recurrent VTE in Patients With Angiographically Confirmed Acute Massive Pulmonary Embolism undergoIng Endovascular Mechanical Fragmentation and Thrombolytic TherapyTreatment